Redispar 0.5 mcg Capsule 10's

Redispar 0.5 mcg Capsule is used to treat secondary hyperparathyroidism in chronic renal disease patients with or without dialysis therapy. Secondary hyperparathyroidism occurs when the parathyroid glands enlarge and produce an excessive amount of PTH, resulting in a high PTH level in the blood.

Redispar 0.5 mcg Capsule contains Doxercalciferol. It promotes the body's consumption of calcium from food or supplements, as well as the management of parathyroid hormone synthesis.

It's available on prescription; take it as directed by your physician. Sometimes, you may experience certain common side effects, including headache, dizziness, heartburn, sleep disorders, joint pain, and weight gain. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, consult a doctor.

Using Redispar 0.5 mcg Capsule is contraindicated in patients who have a history of hypercalcemia, have current evidence of vitamin D toxicity, or are allergic to any of its components. So, before taking Redispar 0.5 mcg Capsule , let your doctor know about all your medical conditions, sensitivities, and all medications you are using. Redispar 0.5 mcg Capsule should be used during pregnancy only if clearly needed, as there are no adequate and well-controlled studies in pregnant women. It is unknown whether Doxercalciferol is excreted in human milk. Considering the importance of the drug to the mother, a decision should be made whether to quit nursing or the medicine. So, inform your doctor if you are pregnant or suspect pregnancy or nursing mother. Your doctor will weigh the benefits and potential risks before prescribing Redispar 0.5 mcg Capsule .

Redispar 0.5 mcg Capsule contains Doxercalciferol, which belongs to the vitamin D analogue class of medications. It promotes the body's consumption of calcium from food or supplements, as well as the management of parathyroid hormone synthesis. Thus, Doxercalciferol helps to treat secondary hyperparathyroidism in chronic renal disease patients.

• Headache
• Dizziness
• Heartburn
• Sleep disorders
• Joint pain
• Weight gain

Do not take Redispar 0.5 mcg Capsule if you are allergic to any of its ingredients. Inform about all your medical conditions, sensitivities, and all medications you are using. Redispar 0.5 mcg Capsule should not be used in pregnant women or nursing mothers unless clearly necessary. So, inform your doctor if you are pregnant or suspect pregnancy or nursing mother. Your doctor will weigh the benefits and potential risks before prescribing Redispar 0.5 mcg Capsule .

Drug-Drug Interactions: Redispar 0.5 mcg Capsule may interact with certain medicines used to treat duodenal ulcers (e.g. sucralfate), and certain medicines or supplements contain vitamin D or cholecalciferol.

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: Redispar 0.5 mcg Capsule may interact with various disease conditions, including hypercalcemia (too much calcium in the blood.), and liver dysfunction.

• SUCRALFATE
• VITAMIN D
• CHOLECALCIFEROL

• Consume a well-balanced and healthy diet.
• Keep your weight under control with a BMI of 19.5-24.9
• Eat low-phosphorus foods such as sourdough bread, corn or rice cereals, cream of wheat, unsalted popcorn and some light-coloured sodas & lemonade.
• Avoid high-phosphorus foods, including bran cereals, oatmeal, nuts, sunflower seeds, whole-grain bread and dark-coloured colas.
• Limit or avoid alcohol consumption.
• Quitting smoking is the best strategy to lower the risk of illness.

• Monitor your calcium levels regularly during treatment with Redispar 0.5 mcg Capsule . Inform your doctor if you notice signs of low calcium levels, such as numbness or tingling around the mouth or muscle aches.

Secondary hyperparathyroidism: Secondary hyperparathyroidism occurs when the parathyroid glands enlarge and produce excessive PTH, resulting in a high PTH level in the blood. There are various reasons why this occurs in kidney disease patients: Higher blood phosphorus levels, the inability of the kidneys to produce active vitamin D (required for calcium absorption), and lower blood calcium levels.